Monday, November 26, 2018

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSXV: $LVWL.V) (TSX: $TRST.TO) (TSX: $WEED.TO) (NYSE: $CGC) (TSXV: $N.V)

Investorideas.com - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSXV: $LVWL.V) (TSX: $TRST.TO) (TSX: $WEED.TO) (NYSE: $CGC) (TSXV: $N.V)



Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSXV: $LVWL.V) (TSX: $TRST.TO) (TSX: $WEED.TO) (NYSE: $CGC) (TSXV: $N.V)

This month's cannabis podcasts brought to you by CLS Holdings USA, Inc. (OTCQB: $CLSH) @CLSHusa


Delta, Kelowna, BC - November 26, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified cannabis company operating as Cannabis Life Sciences  an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.
Listen to the podcast:

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSXV: $LVWL.V) (TSX: $TRST.TO) (TSX: $WEED.TO) (NYSE: $CGC) (TSXV: $N.V)

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:
Good afternoon, welcome to another Investorideas.com “potcast”, featuring stocks to watch, cannabis news as well as insights from thought leaders and experts.
Today we will be looking at announcements from LiveWell Canada Inc. (TSXV:LVWL), CannTrust Holdings Inc. (TSX: TRST), Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and Namaste Technologies Inc. (TSXV:N) (OTCMKTS:NXTTF).
LiveWell Canada Inc. has been approved to list its common shares on the Canadian Securities Exchange (CSE).  As a result, the Company will voluntarily delist its common shares from the TSXV. The transition will happen seamlessly, with LiveWell listing on the CSE starting today and the delisting from the TSXV will take place in the near future.
Moving to the CSE will allow LiveWell to accelerate its growth plans to become a global leader in the CBD market without restrictions on operating in certain international markets.
"LiveWell is preparing for its transformative progression to a global life sciences company leveraging robust CBD supply chain production capacity, while focusing on a brand development strategy that prioritizes functional products and outcomes," said David Rendimonti, President and CEO of LiveWell Canada Inc. "The CSE embraces transforming companies like LiveWell who are growing beyond the Canadian borders," he added.
Legalization and acceptance of CBD for its health and wellness benefits are accelerating at a rapid pace globally. CBD derived from hemp faces fewer legal restrictions worldwide than cannabis. The Brightfield Group of Chicago estimates the North American market alone for CBD from hemp could reach US$22 billion by 2022.  While hemp cultivation, processing and sale activities are currently legal in the U.S., as per the State Farm Act, the anticipated passage of the Hemp Farming Act of 2018 would legalize hemp federally before the end of the year and essentially create the same business environment for hemp as any other agricultural commodity.
CannTrust Holdings Inc., one of Canada's leading and most trusted licensed producers of cannabis, announced today that it has shipped its standardized CBD oil capsules to Australia's Gold Coast University Hospital. The capsules will be used in a study to determine the efficacy of CannTrust CBD oil capsules in slowing the disease progression in patients with Amyotrophic Lateral Sclerosis (ALS) and Motor Neuron Disease (MND), which was first announced by the Company in July 2018. The capsules will be imported, stored and distributed by PharmaCann Pty Ltd ("PharmaCann"). The shipment will include all investigational products that are required for the study.
This study exemplifies CannTrust's focus on medical research and its dedication to uncovering the medicinal value of its proprietary cannabis products, and how they can improve health and well-being for all. In addition to assessing ALS disease progression, the study will also look at the effects of CannTrust CBD oil capsules on a variety of outcome measures related to ALS such as spasticity, pain, weight loss and quality of life. The CBD strain which will be used in the study was developed by CannTrust from its proprietary genetics, meaning that the research results will be specific to the Company's CBD oil.
Canopy Growth Corporation has closed the previously announced acquisition of the assets of ebbu, Inc. ("ebbu"), a leader in hemp research and innovation.
Intellectual Property ("IP") and R&D advancements achieved by ebbu's team apply directly to Canopy Growth's hemp and THC-rich cannabis genetic breeding program and its cannabis-infused beverage capabilities. In addition, ebbu's IP portfolio will contribute to the clinical formulations program executed by Canopy Health Innovations, a wholly owned subsidiary of the Company.
Canopy Growth operates a rapidly emerging, field-scale hemp operation based in Saskatchewan and by applying ebbu's IP, the Company has the potential to vastly reduce the cost of CBD production, a sought-after cannabinoid in both the wellness and medical spaces.
Staying with Canopy Growth's long-held position on business operations in the United States, this transaction would not have been finalized were it not in clear accordance with US federal law, along with the requisite exchange consent by the TSX. Canopy Growth, through a newly formed subsidiary, will employ ebbu's assets and personnel to conduct R&D. There will be no production or sale of products resulting from such R&D in the United States unless and until it would be federally legal to do so.
Namaste Technologies Inc. announced that the Company has signed a Subscription Agreement, whereby the Company has completed an investment of $250,000 to acquire 46,729 Class B common shares of Kief Cannabis Company Ltd. at a cost of $5.35 per share. Namaste's investment represents approximately 3% of the issued and outstanding shares of Kief Cannabis, based on an $8.1 million valuation.
Further to the Company's August 29, 2018 news release where Namaste's wholly-owned subsidiary, Cannmart Inc. signed a medical cannabis Supply Agreement to purchase premium medical cannabis products from Kief Cannabis for sale on its online platform, Cannmart will now also have the right of first refusal ("ROFR") on 35% of the total production of cannabis from Kief Cannabis.
This investment and additional security of supply bolsters Namaste's objective to become Canada's premier online medical cannabis retailer. In September, the Company received its ACMPR Sale for Medical Purposes licence, the first of its kind to be issued by Health Canada, allowing Canadian customers the ability to purchase medical cannabis from wide assortment of licensed producers through Namaste's platform, giving consumers the power of choice rather than having to register with just one LP.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by

CLS Holdings USA, Inc. (OTCQB: CLSH)
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
For additional information, please visit: http://www.clsholdingsinc.com
Twitter: @CLSHusa

Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411

No comments: